Congress · 14. November 2018
SYnAbs is waiting for you at Medica on booth H3K74! See you there to discuss custom mAb generation projects against tricky antigens: polysaccharide, steroid, PTM on DNA, lipid, small molecule, peptide...
Congress · 31. October 2018
SYnAbs is looking for distributors in Australia for its unique catalog of secondary monoclonal antibodies, isotype controls and anti-isotypes references
Distribution agreement · 01. October 2018
SYnAbs is entering into a strategic deal with DBA Italia for distribution of unique mAbs in Italy!
Organic growth · 28. August 2018
SYnAbs is proud to announce ISO 9001:2015 certification! One more step one the path of excellence in antibodies services and products!
Distribution agreement · 27. July 2018
SYnAbs presence in China through Dakewe Biotech Co. Strong partnership to address monoclonal antibodies field.
Organic growth · 25. June 2018
Pour faire face à une demande grandissante et afin d’accélérer sa croissance, SYnAbs cherche aujourd’hui à élargir son équipe avec de nouveaux employés à fort potentiel. SYnAbs est une société d’innovation en biotechnologie qui a développé une expertise dans la génération d’anticorps monoclonaux uniques à partir des espèces animales de rat et de cochon d’Inde. Née à la fin 2015, et fort d’une expérience éprouvée en culture cellulaire et purification, SYnAbs a...
Congress · 19. June 2018
SYnAbs was present in Oxford, UK, attending the 10th anniversary of Pivotal Scientific team!
Congress · 06. February 2018
SYnAbs has presented its one-stop-shop offer in CAR-T from CAR design to anti-ScFv generation!
Congress · 01. February 2018
SYnAbs attended Innovation for Health congress in Rotterdam, Netherlands to promote custom mAb generation services in rat and guinea pig species to obtain monoclonal antibodies of higher affinity and better specificity against difficult targets